isoalantolactone has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Jia, Y; Song, X; Xie, L; Xiong, J; Yao, Y; Ying, S; Yuan, J; Zeng, Z; Zhang, C | 1 |
| Ding, C; Fang, X; Gao, H; Gao, R; Khan, M; Li, T; Ma, T; Rasul, A; Yi, F; Zhang, K; Zhong, L | 1 |
2 other study(ies) available for isoalantolactone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Sesquiterpenes; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Immunoblotting; Lipid Peroxidation; Membrane Potential, Mitochondrial; Pancreatic Neoplasms; Reactive Oxygen Species; Sesquiterpenes | 2012 |